Related Experiment Video
Updated: Jan 1, 2026
Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Recent advances in understanding and managing pediatric inflammatory bowel disease
Bhaskar Gurram1, Ashish S Patel1
1University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Insights
Pediatric inflammatory bowel disease (IBD) treatments are advancing rapidly, moving beyond anti-tumor necrosis factor agents. New therapies focus on personalized approaches, offering hope for future cures in pediatric IBD.
Area of Science:
- Pediatric gastroenterology
- Inflammatory Bowel Disease (IBD) research
- Therapeutic development
Background:
- Pediatric IBD landscape is evolving quickly.
- Adult therapeutic advances are being adopted for children.
- Anti-tumor necrosis factor (TNF) agents have been a mainstay therapy.
Purpose of the Study:
- To review current and novel therapeutics for pediatric IBD.
- To frame the discussion of pediatric IBD treatment.
- To highlight the shift towards personalized therapy.
Main Methods:
- Review of epidemiology and pathophysiology of pediatric IBD.
- Analysis of current therapeutic strategies.
- Evaluation of novel treatment targets and mechanisms of action.
Main Results:
- Expansion of therapeutic targets beyond anti-TNF agents.
- Increased focus on individualized and personalized medicine in pediatric IBD.
- Real-world data complementing controlled trial findings.
Conclusions:
- Current therapeutic era offers hope for pediatric IBD.
- Continued scientific discovery may lead to a cure.
- Personalized therapy is a key trend in pediatric IBD management.
Abstract:
The landscape of pediatric inflammatory bowel disease is rapidly evolving. The therapeutic advances seen in the adult arena are rapidly being adopted by pediatric gastroenterologists and evaluated in both controlled trials and real-world experience. Though anti-tumor necrosis factor agents have been the primary therapy over the last decade, recently there has been an expansion of therapeutic targets and alternative mechanism of action drugs with a focus on individualized and personalized therapy. By reviewing epidemiology, pathophysiology, and goals of treatment, we hope to frame the discussion of current and novel therapeutics for the pediatric gastroenterologist. As scientific discovery continues to push the envelope in defining our understanding of pediatric inflammatory bowel disease, the current era of therapeutics gives us hope that a cure may be realized soon.
Related Concept Videos
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents